Bayer & Monsanto v. Irions: $2.26M Judgment for Xtend Soybean Patent Infringement
Bayer AG and Monsanto Technology LLC secured summary judgment against Missouri farmer Brian Irions for infringing two biotech soybean patents — US7838729B2 and US9944945B2 — and breaching Technology Stewardship Agreements across three growing seasons. The court awarded $2,262,535 in liquidated damages and issued a permanent injunction, closing the case after 694 days.
Biotech seed giant wins $2.26M judgment against Missouri farmer for three-year Xtend infringement
Filed on 25 January 2023 in the Eastern District of Missouri before Judge John A. Ross, this case pitted Bayer AG and its subsidiary Monsanto Technology LLC against Missouri farmer Brian G. Irions. The plaintiffs asserted two patents — US7838729B2, covering soybean event MON89788 detection methods, and US9944945B2, covering chloroplast transit peptides enabling dicamba tolerance in Xtend crops — alongside breach-of-contract claims under Technology Stewardship Agreements signed for the 2020, 2021, and 2022 growing seasons.
On 19 December 2024, the court entered summary judgment in favor of Bayer CropScience LP and Monsanto Technology LLC on all counts. Irions was found liable for patent infringement of both the ‘729 and ‘945 patents and for breaching the TSAs across all three contract years. The court awarded $2,262,535 in liquidated damages — a figure derived from the pre-negotiated TSA damage provisions — and issued a permanent injunction prohibiting Irions from saving, planting, selling, or transferring any seed containing plaintiffs’ patented biotechnologies without written permission, and from applying unapproved dicamba formulations to Xtend crops.
The 694-day duration from filing to final judgment is consistent with a well-developed summary judgment record in a technically complex agricultural biotech case. The liquidated damages quantum suggests Irions planted or saved substantial volumes of proprietary seed across multiple seasons. What the public record does not reveal is whether settlement negotiations occurred before trial, the precise acreage involved, or whether Irions plans to appeal — factors that could affect the permanence of the injunction and ultimate recovery.
Filing to Judgment on the merits for Plaintiff in 694 days
694 days from filing to final judgment — consistent with contested summary judgment proceedings in E.D. Missouri patent cases
Summary judgment for plaintiffs: what the $2.26M ruling means for both parties
Summary judgment on infringement and contract breach — no trial needed
Summary judgment is granted when there is no genuine dispute of material fact and the moving party is entitled to judgment as a matter of law. Here, the court found the infringement of both the ‘729 and ‘945 patents and the breach of three TSA contracts sufficiently clear on the record that no jury trial was required. This signals that Irions could not raise a credible factual defence on either patent validity, non-infringement, or contract performance.
Decided on the merits — no trialBayer and Monsanto secure injunction and full liquidated damages recovery
The plaintiffs obtained both monetary and equitable relief. The $2,262,535 liquidated damages award reflects the TSA’s pre-set per-unit or per-acre multipliers — a mechanism designed to make enforcement economically viable without proving actual damages. The permanent injunction goes further, barring Irions from any future use of the patented seed technology without written consent, and from applying unapproved dicamba formulations to Xtend crops after applicable deadlines. This dual remedy comprehensively protects Bayer’s downstream licensing model.
Full monetary + equitable reliefIrions faces $2.26M liability and permanent operational restrictions on his farming
The judgment imposes significant financial and operational consequences on Irions. Beyond the damages award, the permanent injunction restricts how he sources, uses, and disposes of soybean seed going forward — effectively barring participation in Bayer’s Xtend ecosystem without explicit permission. His options now include satisfying the judgment, negotiating a post-judgment settlement, or pursuing an appeal to the Eighth Circuit, though the summary judgment standard makes a successful appeal challenging.
Permanent injunction issuedA clear enforcement signal to the agricultural biotech seed-saving market
This outcome reinforces Bayer’s and Monsanto’s willingness to litigate TSA breaches to final judgment rather than settle quietly. The liquidated damages clause — validated by the court — removes the burden of proving lost profits, making each farmer-level enforcement action commercially viable. For competitors and ag-tech developers, the ‘945 and ‘729 patents remain enforceable and court-tested. Growers operating outside TSA terms face a clear precedent that seed saving across multiple seasons will attract compounding liability.
TSA enforcement precedent setFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Bayer AG | Company | Agricultural biotech — holder of US7838729B2 (MON89788) and US9944945B2 (DMO transit peptides)Search in Eureka ↗ |
| Co-Plaintiff | Monsanto Technology, LLC | Company | Search in Eureka ↗ |
| Defendant | Brian G. Irions | Individual | Missouri farmer alleged to have saved and planted proprietary Xtend soybean seed across 2020–2022Search in Eureka ↗ |
| Plaintiff counsel | Anthony F. Blum | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Daniel C. Cox | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Jeffrey A. Masson | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Matthew S. Bober | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff law firm | Thompson Coburn LLP (St Louis) | Law Firm | Representing Bayer AGSearch in Eureka ↗ |
| Defendant counsel | Wendell L. Hoskins , II | Attorney | Counsel for Brian G. IrionsSearch in Eureka ↗ |
| Defendant law firm | Hoskins Law Office | Law Firm | Representing Brian G. IrionsSearch in Eureka ↗ |
| Presiding judge | Judge John A. Ross | Judge | Missouri Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s summary judgment order finds Irions liable on both patent and contract grounds without ambiguity — the verdict text specifies each patent by number, names each TSA year, and quantifies damages precisely at $2,262,535. This level of specificity in the order suggests a well-developed evidentiary record with no material factual disputes remaining. The dual basis of liability — patent infringement plus contract breach — means any appeal would need to defeat both legal theories to obtain relief, significantly narrowing appellate prospects for the defendant.
US7838729B2 & US9944945B2 — Xtend Soybean Biotech: MON89788 and DMO Transit Peptides
US7838729B2 (application no. US11/758659) covers methods for detection of soybean event MON89788 — the genetic event underpinning Bayer’s Roundup Ready 2 Xtend soybean platform, enabling herbicide tolerance traits to be tracked and verified in seed and plant tissue. US9944945B2 (application no. US14/539923) protects chloroplast transit peptide sequences used to efficiently target the dicamba monooxygenase (DMO) enzyme into chloroplasts, conferring tolerance to dicamba-based herbicides. Together these patents protect the core detection and expression architecture of the Xtend trait stack.
Strategically, these two patents anchor Bayer’s ability to enforce its Xtend soybean licensing model at multiple levels: the ‘729 patent enables detection of unauthorised seed use in the field, while the ‘945 patent protects the underlying biochemical mechanism that makes Xtend crops commercially valuable. Any soybean seed developer attempting to engineer dicamba tolerance or commercialise MON89788-adjacent events must conduct a thorough FTO analysis against both patents — this judgment confirms their validity and enforceability in a contested E.D. Missouri proceeding.
Should you run an FTO against US7838729B2 and US9944945B2?
Any company or research institution developing dicamba-tolerant soybean varieties, engineering novel chloroplast transit peptide sequences for herbicide tolerance applications, or creating detection assays for proprietary soybean events should assess freedom-to-operate against both of these patents. Seed companies, ag-biotech startups, and CRISPR-based trait developers working in the soybean herbicide-tolerance space are particularly exposed — especially if their commercial pipeline involves traits that overlap with MON89788 or DMO-based expression systems.
PatSnap Eureka’s FTO Search Agent can map your candidate sequences, expression constructs, and detection methodologies against the claim scope of US7838729B2 and US9944945B2 in minutes. Eureka identifies relevant prior art, flags potentially blocking claims, and surfaces related Bayer and Monsanto portfolio patents that may create a broader exclusionary zone around Xtend-adjacent technologies — giving your R&D and legal teams the intelligence needed to design around risk before committing to development spend.
Run a freedom-to-operate analysis on US7838729B2 to assess your product’s exposure
Run FTO in Eureka →Similar Xtend soybean patent enforcement cases in U.S. district courts
Cases below involve Monsanto or Bayer asserting biotech seed patents and TSA breach claims against growers in U.S. district courts — directly comparable to this E.D. Missouri action.
What this case signals for the agricultural biotech IP enforcement landscape
This judgment confirms that Bayer and Monsanto continue to pursue individual growers through the courts — and win — making TSA compliance a genuine legal risk, not a formality.
Liquidated damages clauses in TSAs are court-enforceable and bypass actual damage proof
The $2.26M award derived from TSA liquidated damages provisions — not proved lost profits — signals that Bayer’s contract structure is robust under Missouri law. Any seed company or ag-tech licensor structuring similar agreements should note that courts will enforce pre-set per-season multipliers when the underlying breach is clear.
Multi-season infringement dramatically compounds exposure for defendant farmers
Irions was found liable across the 2020, 2021, and 2022 seasons. Each additional season of seed saving appears to have added independently to the damages calculation. Growers using patented biotech traits without annual TSA compliance face an exposure that compounds with every growing season — a structure Bayer has now had validated by an Article III court.
Bayer v Brian — key questions answered
The Eastern District of Missouri entered summary judgment for Bayer CropScience LP and Monsanto Technology LLC on 19 December 2024. Defendant Brian Irions was found liable for infringing US7838729B2 and US9944945B2 and for breaching Technology Stewardship Agreements for 2020, 2021, and 2022. The court awarded $2,262,535 in liquidated damages and issued a permanent injunction against further unauthorised seed use and unapproved dicamba applications.
Two patents were asserted: US7838729B2 (application US11/758659), covering soybean event MON89788 detection methods, and US9944945B2 (application US14/539923), covering chloroplast transit peptides for targeting the dicamba monooxygenase enzyme. Both patents underpin Bayer’s Xtend soybean platform, covering both the detection of the proprietary trait and the molecular mechanism enabling dicamba herbicide tolerance.
A Technology Stewardship Agreement (TSA) is a licensing contract growers sign when purchasing Bayer or Monsanto patented biotech seed. It sets out permitted uses — including prohibitions on seed saving — and typically contains liquidated damages provisions. In this case, Irions was found to have breached TSAs for three consecutive seasons (2020–2022), and the court enforced the pre-agreed liquidated damages, awarding $2,262,535 without requiring proof of actual lost profits.
The court permanently enjoined Irions from making, using, saving, planting, selling, offering to sell, importing, or transferring any soybean or other seed containing Bayer’s or Monsanto’s patented biotechnologies without express written permission. The injunction also prohibits him from applying unapproved formulations of dicamba-based herbicides to Xtend crops, including applications made after the applicable seasonal deadlines set by regulators and the TSA.
The case ran for 694 days, from filing on 25 January 2023 to final judgment on 19 December 2024. It was resolved on summary judgment, meaning the court determined there were no genuine disputes of material fact requiring a jury trial. This outcome typically suggests the defendant could not mount a credible factual challenge to the infringement or contract breach allegations on the record developed during discovery.
PatSnap Eureka searches patents and litigation data to answer instantly.